From Optimalized Biomanufacturing to Transformational Cancer Therapy

Torrey was founded on a biologic CMC technology designed to enhance mammalian cell-based manufacturing efficiency.  This technology requires a de-risking mechnisam for potential oncogenesis of booster genes used in cell culture production.  That same mechanism, upon optimization, has evolved into the platform of Tumor Cell Immunogenization (TCI) to treat advanced cancers.

The result is a single technology with two transformative applications: safe, higher-yield biomanufacturing of biologic drugs, and an abscopal oncotherapy against metastasis.